FDA Inspection
Eagle Indo Pharma, PTEagle Indo Pharma, PT – FDA Inspection, Mar 29, 2018
Record Details
This FDA Inspection record concerns Eagle Indo Pharma, PT, with an inspection on March 29, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Reba A. Gates (Issuing Officer)
View Company Profile
ID · bd5a655b-47c8-4c1d-8491-329de3434988
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049561
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.